Fred H.P. De Koning

948 total citations
13 papers, 678 citations indexed

About

Fred H.P. De Koning is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Toxicology. According to data from OpenAlex, Fred H.P. De Koning has authored 13 papers receiving a total of 678 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 5 papers in Geriatrics and Gerontology and 4 papers in Toxicology. Recurrent topics in Fred H.P. De Koning's work include Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical studies and practices (5 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). Fred H.P. De Koning is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (5 papers), Pharmaceutical studies and practices (5 papers) and Pharmacovigilance and Adverse Drug Reactions (4 papers). Fred H.P. De Koning collaborates with scholars based in Netherlands, Sweden and New Zealand. Fred H.P. De Koning's co-authors include Toine C. G. Egberts, Ronald H.B. Meyboom, Yechiel A. Hekster, Frank W.J. Gribnau, I. Ralph Edwards, Hubert G. M. Leufkens, H.G.M. Leufkens, Maartje Smulders, R.H.B. Meyboom and Hieronymus J. Derijks and has published in prestigious journals such as British Journal of Clinical Pharmacology, Drug Safety and European Journal of Clinical Pharmacology.

In The Last Decade

Fred H.P. De Koning

13 papers receiving 635 citations

Peers

Countries citing papers authored by Fred H.P. De Koning

Since Specialization

Citations

This map shows the geographic impact of Fred H.P. De Koning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred H.P. De Koning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred H.P. De Koning more than expected).

Fields of papers citing papers by Fred H.P. De Koning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred H.P. De Koning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred H.P. De Koning. The network helps show where Fred H.P. De Koning may publish in the future.

Co-authorship network of co-authors of Fred H.P. De Koning

This figure shows the co-authorship network connecting the top 25 collaborators of Fred H.P. De Koning. A scholar is included among the top collaborators of Fred H.P. De Koning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred H.P. De Koning. Fred H.P. De Koning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Feasibility of point-of-care creatinine testing in community pharmacy to monitor drug therapy in ambulatory elderly patients 2013 ·Journal of Clinical Pharmacy and Therapeutics ·(unknown), Fred H.P. De Koning, Karen M. K. de Vooght, Toine C. G. Egberts, Peter A. G. M. De Smet, Wouter W. van Solinge	24
2	Information comparison of the effects of drugs on laboratory tests in drug labels and Young’s book 2012 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Fred H.P. De Koning, Toine C. G. Egberts, Peter A. G. M. De Smet, Wouter W. van Solinge	3
3	Instructions on laboratory monitoring in 200 drug labels 2012 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Fred H.P. De Koning, Wouter W. van Solinge, Peter A. G. M. De Smet, Toine C. G. Egberts	12
4	Pharmacist-Based Medication Review Reduces Potential Drug-Related Problems in the Elderly 2009 ·Drugs & Aging ·(unknown), Toine C. G. Egberts, (unknown), Fred H.P. De Koning	114
5	Laboratory Tests in the Clinical Risk Management of Potential Drug-Drug Interactions 2009 ·Drug Safety ·(unknown), Fred H.P. De Koning, Peter A. G. M. De Smet, Wouter W. van Solinge, Toine C. G. Egberts	16
6	Visualizing Pharmacological Activities of Antidepressants: A Novel Approach 2008 ·Data Archiving and Networked Services (DANS) ·Hieronymus J. Derijks, Eibert R. Heerdink, R. Janknegt, Fred H.P. De Koning, Berend Olivier, A.J.M. Loonen, Toine C. G. Egberts	24
7	The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports 2008 ·European Journal of Clinical Pharmacology ·Hieronymus J. Derijks, Ronald H.B. Meyboom, Eibert R. Heerdink, Fred H.P. De Koning, R. Janknegt, Marie Lindquist, Toine C. G. Egberts	76
8	Identification of Potential Drug-related Problems in the Elderly: The Role of the Community Pharmacist 2006 ·Pharmacy World & Science ·(unknown), Fred H.P. De Koning, (unknown), Toine C. G. Egberts	70
9	Principles of Signal Detection in Pharmacovigilance 1997 ·Drug Safety ·Ronald H.B. Meyboom, Toine C. G. Egberts, I. Ralph Edwards, Yechiel A. Hekster, Fred H.P. De Koning, Frank W.J. Gribnau	162
10	Channeling of Three Newly Introduced Antidepressants to Patients Not Responding Satisfactorily to Previous Treatment 1997 ·Journal of Clinical Psychopharmacology ·Toine C. G. Egberts, A.W. Lenderink, Fred H.P. De Koning, Hubert G. M. Leufkens	27
11	ADR related questions received by a telephone medicines information service and ADRs received by a spontaneous ADR reporting system: a comparison regarding patients and drugs 1997 ·Pharmacoepidemiology and Drug Safety ·Toine C. G. Egberts, Fred H.P. De Koning, Ronald H.B. Meyboom, Hubert G. M. Leufkens	8
12	Non‐puerperal lactation associated with antidepressant drug use 1997 ·British Journal of Clinical Pharmacology ·Toine C. G. Egberts, Ronald H.B. Meyboom, Fred H.P. De Koning, Albert Bakker, Hubert G. M. Leufkens	52
13	Can adverse drug reactions be detected earlier? A comparison of reports by patients and professionals: Fig 1 1996 ·BMJ ·Toine C. G. Egberts, Maartje Smulders, Fred H.P. De Koning, R.H.B. Meyboom, H.G.M. Leufkens	90

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact